| (USD) | Jun 2026 | Y/Y change |
|---|---|---|
| Revenue | 41.00M | — |
| Operating expense | — | — |
| Net income | -91.00M | — |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, RCUS returned +188.1% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | +27.3% |
| 1 year | +188.1% |
| 5 years | +4.0% |
| All-time high | $43.80 (Nov 2021) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what $1,000 in RCUS would be worth today ›No. Arcus Biosciences, Inc. has not paid a dividend in the past 12 months.
Arcus Biosciences, Inc. stock trades on NYSE under the ticker symbol RCUS.
Arcus Biosciences, Inc. is part of the Healthcare sector.
Arcus Biosciences, Inc. has a market cap of 3.82B USD, based on the latest quote.
Arcus Biosciences, Inc. is expected to report earnings around Oct 27, 2026. That date is an estimate and has not been confirmed by the company.
